Moderna Stock in 2024: A Global Financial Perspective
Moderna, once a relatively obscure biotechnology firm, became a household name during the COVID-19 pandemic. Its mRNA vaccine, developed in record time, played a pivotal role in global health efforts. Today, Moderna stock remains a topic of intense discussion among investors, analysts, and the public. This article explores the company’s trajectory, its impact on global…
